Hyperlipidemia: References

1. Lin J, Yang R, Tarr PT, et al. Hyperlipidemic effects of dietary saturated fats mediated through PGC–1β coactivation of SREBP. Cell. 2005;120:261–273

2. Sharett AR, Ballantyne M, Coady SA, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A–I and B, and HDL density subfractions. The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2001;104:1108–1113.

3. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–3421.

4. O’Keefe JH Jr, Cordain L, Harris WH, Moe RM, Vogel R. Optimal low–density lipoprotein is 50 to 70 mg/dL: lower is better and physiologically normal. J Am Coll Cardiol 2004;43:2142–2146.

5. Grundy SM, Cleeman JI, Merz CNB, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 2004;110:227–239.

6. Hata Y, Nakajima K. Life–style and serum lipids and lipoproteins. J Atheroscler Thromb. 2000;7:177–197.

7. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol. 2000;86:943–949.

8. Hunninghake DB, Stein EA, Dujovne CA, et al. The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. N Engl J Med. 1993;328:1213–1219.

9. Ornish D, Scherwitz LW, Billings JH, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998;280:2001–2007.

10. Barnard ND, Scialli AR, Bertron P, Hurlock D, Edmonds K, Talev L. Effectiveness of a low–fat vegetarian diet in altering serum lipids in healthy premenopausal women. Am J Cardiol. 2000;85:969–972.

11. Pelkman CL, Fishell VK, Maddox DH, Pearson TA, Mauger DT, Kris–Etherton PM. Effects of moderate–fat (from monounsaturated fat) and low–fat weight–loss diets on the serum lipid profile in overweight and obese men and women. Am J Clin Nutr. 2004;79:204–212.

12. Peters JC. Dietary fat and body weight control. Lipids. 2003;38:123–127.

13. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet.1990 ;336:129–133.

14. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol–lowering effects of dietary fiber: a meta–analysis. Am J Clin Nutr. 1999; 69:30–42.

15. Jenkins DJ, Kendall CW, Vuksan V, et al. Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. Am J Clin Nutr. 2002;75: 834–839.

16. Jenkins DJ, Wolever TM, Kalmusky J, et al. Low–glycemic index diet in hyperlipidemia: use of traditional starchy foods. Am J Clin Nutr. 1987;46:66–71.

17. Anderson JW, Johnstone BM, Cook–Newell ME. Meta–analysis of the effects of soy protein intake on serum lipids. N Eng J Med. 1995;333:276–282. 

18. Kris–Etherton PM, Yu–Poth S, Sabate J, Ratcliffe HE, Zhao G, Etherton TD. Nuts and their bioactive constituents: effects on serum lipids and other factors that affect disease risk. Am J Clin Nutr. 1999;70:504S–511S.

19. Hu FB, Manson JE, Willett WC. Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr. 2001;20:5–19.

20. Katan MB, Grundy SM, Jones P, et al. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc. 2003;78:965–978.

21. Jenkins DJ, Kendall CW, Marchie A, et al. Effects of a dietary portfolio of cholesterol–lowering foods vs lovastatin on serum lipids and C–reactive protein. JAMA. 2003;290:502–510.

22. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta–analysis of effects on lipids and haemostatic factors. BMJ. 1999;319:1523–1528.

23. Malloy MJ, Kane JP. A risk factor for atherosclerosis: triglyceride–rich lipoproteins. Adv Intern Med. 2001;47:111–136.